--The objective of Phase I clinical trial is to identify a safe and efficacious dose for the pivotal Phase II/III in COVID-19 patients. Phase I clinical trial is expected to be completed within the first quarter of 2023 --Phase I clinical ...
OTTAWA , TRADITIONAL UNCEDED ALGONQUIN TERRITORY, ON , Dec. 2, 2022 /CNW/ - As people are spending more time together indoors, respiratory illnesses are increasing this fall. One of the best ways to protect yourself from becoming really ...
CHICAGO , Dec. 1, 2022 /PRNewswire/ -- COVID-19 infection is associated with increased liver stiffness, a sign of possible long-term liver injury, according to the results of a new study being presented today at the annual meeting of ...
Parsippany,N.J., Nov. 29, 2022 /PRNewswire/ -- Royal DSM, a global science-based company active in Health, Nutrition and Bioscience, comments on the findings from a recently published paper in Nature Medicine which reported that ...
HANGZHOU, China and SHAOXING, China , Nov. 28, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that the Investigational New Drug (IND) application of ASC11, an oral inhibitor drug candidate targeting ...
In a new clinical study, peer-reviewed and published in the November 2022 issue of "Lifestyle Medicine" by John Wiley & Sons Ltd, medical researchers found that the regular practice of AMI Meditation and its allied disciplines ...
MORRISVILLE, N.C. , Nov. 21, 2022 /PRNewswire/ -- Immorna, a rapidly expanding biotechnology company, focusing on the development of multi-platform RNA-based therapeutics and vaccines, today announced that the U.S. Food and Drug ...
CHICAGO , Nov. 21, 2022 /PRNewswire/ -- Using a special type of MRI, researchers have uncovered brain changes in patients up to six months after they recovered from COVID-19, according to a study being presented next week at the annual ...
FinancialNewsMedia.com News Commentary - Since the beginning of the pandemic, the critical effort of researchers is to understand how coronavirus damages the body. PALM BEACH, Fla. , Nov. 17, 2022 /PRNewswire/ -- Research and ...
New Work Focuses on Surveillance of Post COVID-19 Conditions SALT LAKE CITY , Nov. 17, 2022 /PRNewswire-PRWeb/ -- A collaboration of BeyondHIE members and partners has recently been awarded a grant by the Centers for Disease Control and ...
COVID-19 vaccines prove equally effective for adults with anxiety, depression , or mood disorders as for those without such diagnoses. This pioneering study marks a crucial step in...
Four years ago, on a balmy March evening, India implemented an unprecedented nationwide lockdown in response to early concerns about the Covid-19 pandemic ( ), imposing extensive restrictions on public movement...
The most recent series of Covid-19 vaccines provided no additional defense against the JN.1 variant, which remains in circulation. JN.1, from the lineage of Omicron , is an off-spin of BA.2.86.The variant, first detected in Luxembourg in ...
A recent study, featured in The Lancet, sheds light on previously unseen insights into the significantly high mortality rates caused by the COVID-19 pandemic worldwide. Countries like Mexico City, Peru, and Bolivia witnessed substantial ...
A study utilizing wearable device data indicates that men with COVID-19 infections are prone to elevated heart and breathing rates, along with higher skin temperatures, compared to women. ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers